Discover What’s Next for Infant Nutrition
Following high-profile contamination recalls, the implementation of Operation Stork Speed, and growing consumer scrutiny around ingredient safety, expectations for transparency, compliance, and scientific rigor have never been higher.
As the only forum uniting ingredient providers, formula manufacturers, food tech innovators, regulatory authorities, and academic experts in one focused program, the 3rd Novel Ingredients for Infant Formula Summit went beyond discussion — it accelerated progress from discovery through approval and market entry.
The 2026 edition brought together a pioneering community to explore global submission pathways, align on evidence expectations, and address formulation and stability challenges, while advancing key ingredients such as HMOs, lactoferrin, osteopontin, lysozyme, and specialty lipids — setting the stage for an even more impactful return in 2027.
What You Missed:
Innovative Food Tech’s Presenting
2026 brought together innovative Food Tech executives from Numi, Totality Biosciences, Primogene and more to explore exciting new technologies in producing and scaling a wider range of human milk-like ingredients
Unique Focus on Path to Market
Explored how ingredient decision‑making truly happens, from evidence thresholds to commercial viability, with expert leadership from Novonesis, which offered clear insight into what advances novel ingredients from early screening to full adoption
Collaborative Deep-Dive on Regulatory Submissions
Featured breakthrough insights on aligning global safety expectations and accelerating approval pathways for novel infant formula ingredients, spotlighted evidence design, strategic dossier preparation, and region‑specific regulatory navigation from industry leaders across early‑life nutrition
Explore the 2026 Full Event Guide
- Discover 70+ R&D, regulatory, and commercial leaders from ingredient providers, infant formula manufacturers, foodtech innovators, academia, and government
- Preview 2 days of exclusive insights across novel bioactive discovery, clinical validation, regulatory approval pathways, and formulation challenges
- Discover the 16+ industry-leading voices from Bobbie, Arla, Kendal Nutricare, Novonesis, FrieslandCampina, and more
- Explore dedicated deep-dive sessions navigating evidence expectations in infant formulation, approval pathways & more
- Share easily with your team to assess and mobilize interest
Attending Companies Included
Explore the 2026 Agenda
The summit featured forward-looking sessions on novel bioactives, clinical validation strategies, global regulatory pathways, formulation challenges, and commercial scale-up shaping the future of infant nutrition.
Partner With Us
Connect with senior R&D, regulatory, and commercial leaders across ingredient providers, formula manufacturers, and foodtech companies seeking innovative, evidence-backed solutions to accelerate safe market entry
Join Industry Leaders
Network with decision-makers and innovators defining the next generation of clinically validated regulatory-ready ingredients designed to narrow the gap between formula and human breast milk